Science Explorer Back to mapMap
Discussion
Researcher · Barwon Health · Australia

Inger Helen Olesen

Inger Helen Olesen publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and PARP inhibition in cancer therapy.

OpenAlex
World rank
#1,888,997
of 7,710,434 ranked researchers
Rank in Australia
#56,194
of 140,210
Works
35
Citations
502
Citations per work
14.3
h-index
9
i10-index 8Top 65% in Oncology
Inger Helen Olesen

What does Inger Helen Olesen research?

Inger Helen Olesen's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 22 works · 62.2% of their workMedicine: 22 works · 62.2% of their workOncology: 9 works · 27.0% of their workPulmonary and Respiratory Medicine: 9 works · 25.7% of their workReproductive Medicine: 2 works · 5.4% of their workPublic Health, Environmental and Occupational Health: 1 works · 4.1% of their workEverything else: 9 works · 26.9% of their workLife Sciences: 4 works · 10.9% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 10.9% of their workMolecular Biology: 2 works · 6.8% of their workCancer Research: 1 works · 4.1% of their workTHEIR WORKInger HelenOlesen35works
Life Sciences11%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2262.2%
  2. Everything else926.9%
    1. Biochemistry, Genetics and Molecular Biology410.9%
  1. 1Oncology27% of their works
  2. 2Pulmonary and Respiratory Medicine26% of their works
  3. 3Molecular Biology7% of their works
  4. 4Reproductive Medicine5% of their works
  5. 5Cancer Research4% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Inger Helen Olesen's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, CT Screening, Homologous Recombination, Lung Cancer, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Chemotherapy153 topics
  2. Clinical Trials133 topics
  3. Targeted Therapy102 topics
  4. CT Screening91 topic
  5. Homologous Recombination92 topics
  6. Lung Cancer91 topic
  7. ALK Inhibitors71 topic
  8. EGFR Mutations71 topic
  9. BRCA Mutation61 topic
  10. Biomarkers62 topics
  11. Metastasis62 topics
  12. PARP Inhibitors61 topic
  13. Cancer Incidence41 topic
  14. Mortality Rates41 topic
  15. Chemotherapy-Induced Peripheral Neuropathy31 topic
  16. DNA Damage31 topic
  17. Genomic Analysis31 topic
  18. Genomic Profiles31 topic
  19. Ovarian Cancer31 topic
  20. Repair31 topic
  21. Small-Cell Lung Cancer31 topic
  22. Taxanes31 topic

Where does Inger Helen Olesen work?

Inger Helen Olesen's main affiliation in the publication record is Barwon Health, Australia.

How many publications and citations does Inger Helen Olesen have?

OpenAlex counts 35 works and 502 citations for Inger Helen Olesen, an h-index of 9, ranking #1,888,997 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Inger Helen Olesen. Posts are plain text and can be reported.